Sha Yuhui, Zhang Junyi, Ci Yang, Zhuoga Cidan, Zhao Yuhua, Zhou Lixin, Ni Jun
Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1, Shuaifuyuan, Dongdan, Dongcheng District, Beijing, 100730, China.
Department of Neurology, Tibet Autonomous Region People's Hospital, Lhasa, 850000, China.
Thromb J. 2024 Aug 8;22(1):73. doi: 10.1186/s12959-024-00643-2.
Exposure to a high-altitude environment is a risk factor for cerebral venous thrombosis (CVT) probably due to hypercoagulability. The study aims to explore the unique characteristics of CVT patients in high-altitude areas of China by comparing them with those in plain areas.
We retrospectively included consecutive patients with CVT admitted to Tibet Autonomous Region People's Hospital (altitude 3650 m) and Peking Union Medical College Hospital (altitude 43.5 m) between January 2015 and December 2023. Patients from the plateau and the plain were considered two independent groups in this study. The risk factors, clinical and radiological presentations, treatment, and outcomes were analyzed and compared between the two groups.
A total of 169 patients with CVT were included in the study, 48 patients from plateau and 121 patients from plain. The median age was 27 and 34 years old, and women accounted for 66.7% and 54.5% respectively. Headache (91.7% vs. 71.1%, P = 0.004), altered consciousness (31.3% vs. 16.5%, P = 0.033), hemorrhage (41.7% vs. 19.0%, P = 0.002), and venous infarction (50.0% vs. 25.6%, P = 0.002) on imaging were more common in patients from plateau than those from plain. Pregnancy or puerperium was significantly more common in highland patients (25% vs. 5.8%, P < 0.001). The levels of D-Dimer (1.7 vs. 0.8 mg/L FEU, P = 0.01), fibrinogen (3.7 vs. 3.0 g/L, P < 0.001), hemoglobin (157 vs. 129 g/L, P = 0.01), white blood cells (9.6 vs. 7.5*10/L, P < 0.001) and highly sensitive C-reactive protein (20.2 vs. 3.2 mg/L, P = 0.005) were remarkably higher in highland patients. The percentage of receiving anticoagulant therapy was lower in high-altitude patients (70.8% vs. 93.4%, P < 0.001). Favorable outcome at follow-up was observed in 81.4% of highland patients and 90.7% of lowland patients, with a median follow-up time of 330 days and 703 days respectively.
The more severe clinical and imaging manifestations along with prominent inflammatory and hypercoagulable states were observed in plateau CVT patients, probably due to exposure to the hypoxic environment at high altitude. Pregnancy or puerperium were more common in highland patients. The overall prognosis of CVT patients from both groups were favorable.
暴露于高海拔环境是脑静脉血栓形成(CVT)的一个危险因素,可能是由于血液高凝状态。本研究旨在通过将中国高海拔地区的CVT患者与平原地区的患者进行比较,探讨其独特特征。
我们回顾性纳入了2015年1月至2023年12月期间在西藏自治区人民医院(海拔3650米)和北京协和医院(海拔43.5米)收治的连续性CVT患者。本研究将高原地区和平原地区的患者视为两个独立的组。分析并比较两组患者的危险因素、临床和影像学表现、治疗及预后。
本研究共纳入169例CVT患者,其中48例来自高原地区,121例来自平原地区。中位年龄分别为27岁和34岁,女性分别占66.7%和54.5%。高原地区患者头痛(91.7% 对71.1%,P = 0.004)、意识改变(31.3% 对16.5%,P = 0.033)、出血(41.7% 对19.0%,P = 0.002)及影像学上的静脉梗死(50.0% 对25.6%,P = 0.002)比平原地区患者更常见。高原地区患者妊娠或产褥期明显更常见(25% 对5.8%,P < 0.001)。高原地区患者D-二聚体水平(1.7对0.8mg/L FEU,P = 0.01)、纤维蛋白原水平(3.7对3.0g/L,P < 0.001)、血红蛋白水平(157对129g/L,P = 0.01)、白细胞水平(9.6对7.5×10/L,P < 0.001)及高敏C反应蛋白水平(20.2对3.2mg/L,P = 0.005)显著更高。高原地区患者接受抗凝治疗的比例较低(70.8% 对93.4%,P < 0.001)。高原地区81.4%的患者和低地90.7%的患者随访时预后良好,中位随访时间分别为330天和703天。
高原CVT患者观察到更严重的临床和影像学表现以及显著的炎症和高凝状态,可能是由于暴露于高海拔低氧环境。妊娠或产褥期在高原地区患者中更常见。两组CVT患者的总体预后良好。